Cong Wang, Rong Zeng, Yong Li, & Rongxin He. (2024). Cirsilineol inhibits RANKL-induced osteoclast activity and ovariectomy-induced bone loss via NF-κb/ERK/p38 signaling pathways. BMC.
Chicago Style (17th ed.) CitationCong Wang, Rong Zeng, Yong Li, and Rongxin He. Cirsilineol Inhibits RANKL-induced Osteoclast Activity and Ovariectomy-induced Bone Loss via NF-κb/ERK/p38 Signaling Pathways. BMC, 2024.
MLA (9th ed.) CitationCong Wang, et al. Cirsilineol Inhibits RANKL-induced Osteoclast Activity and Ovariectomy-induced Bone Loss via NF-κb/ERK/p38 Signaling Pathways. BMC, 2024.
Warning: These citations may not always be 100% accurate.